Back to top Open menu arrow
Download PDF Reprints

The Journal of
Clinical Psychiatry
Free access

The Journal of Clinical Psychiatry

Letter to the Editor February 1, 2004

Potential for Detection Bias in the Association Between Olanzapine and Diabetes

;

J Clin Psychiatry 2004;65(2):274-274

Article Abstract

Letter to the Editor

Potential for Detection Bias in the Association Between Olanzapine and Diabetes

Also from JCP

Practitioners Providing Care for Persons with Severe Mental Disorders Should Routinely Screen for Metabolic Dysfunction–Associated Steatotic Liver Disease Delirium as a Precursor to Dementia in Type 2 DM Patients Metabolic Syndrome in Offspring of Bipolar Parents

From the Editors

Live Webinar · Jul 16 A Novel Psychedelic for Postpartum Depression Dr. Kristina M. Deligiannidis shares brand-new phase 2a results on inhaled mebufotenin (GH001), plus how PPD therapeutics evolved from SSRIs to neuroactive steroids. Free, with live Q&A — Thursday, July 16, 12:00 PM ET. Register now

 

About the Authors

This PDF is free for all visitors!

The Journal of Clinical Psychiatry June 2026 cover with featured article titles

Vol 87 • 2026 • Number 2

Read the Current Issue

Original Research

CBT following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial

Original Research

Neuropsychiatric Symptom Clusters and Brain Structure in Alzheimer’s Disease

Systematic Review

Thirty Years of the Diagnostic Criteria for Psychosomatic Research

Original Research

Efficacy of Olanzapine/Samidorphan on Negative Symptoms

Original Research

Comparing Risk Prediction for Suicide Attempts and Deaths After Emergency Department Visits

Clinical and Practical Psychopharmacology

Insomnia, Sleep, and the Use of Sedative-Hypnotic Drugs: Practical Notes
View current Issue

Live Webinar
and Q&A With
Dr Deligiannidis

JULY 16 · REGISTER NOW
Webinar ad featuring Dr. Kristina M. Deligiannidis on PPD treatment options

Subscribe to read
more articles

Subscribe